Hudson Bay Capital Management LP Mannkind Corp Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $128,775 - $279,225	-127,500 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$2.28 - $3.8 $403,240 - $672,068	-176,860 Reduced 58.11%	127,500 $291,000
Q4 2017 Feb 12, 2018	SELL	$2.28 - $6.71 $573,235 - $1.69 Million	-251,419 Reduced 45.24%	304,360 $706,000
Q3 2017 Nov 13, 2017	BUY	$1.15 - $2.29 $639,145 - $1.27 Million	555,779	555,779 $1.21 Million

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.59B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.